Wolfe Research analyst Keegan Carl initiates coverage on UMH Properties (NYSE:UMH) with a Outperform rating.
Raymond James Maintains Outperform on Gossamer Bio, Raises Price Target to $14
Raymond James analyst Steven Seedhouse maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and raises the price target from $10 to $14.